LMR Partners’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-363,500
Closed -$36.9M 1596
2025
Q4
$36.9M Buy
363,500
+343,500
+1,718% +$27.6M 0.07% 124
2025
Q3
$1.09M Hold
20,000
﹤0.01% 898
2025
Q2
$1.06M Sell
20,000
-13,200
-40% -$671K 0.01% 779
2025
Q1
$1.44M Sell
33,200
-36,800
-53% -$1.86M 0.01% 719
2024
Q4
$3.93M Buy
70,000
+40,000
+133% +$2.49M 0.03% 447
2024
Q3
$2.04M Buy
+30,000
New +$1.69M 0.02% 602
2024
Q2
Sell
-183,000
Closed -$12.6M 1162
2024
Q1
$12.6M Buy
+183,000
New +$11.6M 0.13% 155

Other funds holding EXAS

LMR Partners's EXAS Position: Q1 2026 in Review

LMR Partners sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 881,340 shares — an estimated $89.5M sold.

LMR Partners first reported a position in EXAS in Q2 2017 and held it in 16 quarters. The position peaked at $89.5M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • LMR Partners reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • LMR Partners sold 881,340 Exact Sciences shares in Q1 2026, an estimated $89.5M.
  • LMR Partners first reported a position in Exact Sciences in Q2 2017 and held it in 16 quarters.
  • LMR Partners's Exact Sciences position peaked at $89.5M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.